Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia

Schizophrenia Research

Volumn 166, Issue 1-3, 2015, Pages 219-224

  Kippe, Jordyn M ^a   Mueller, Toni M ^a   Haroutunian, Vahram ^b   Meador Woodruff, James H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

B3GNT8; MGAT4A; N glycosylation; O glycosylation; Postmortem brain; Posttranslational modifications

Indexed keywords

BETA 1,3 N ACETYLGLUCOSAMINYLTRANSFERASE 8; MANNOSYL (ALPHA 1,3 )GLYCOPROTEIN BETA 1,4 N ACETYLGLUCOSAMINYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG; HALOPERIDOL; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT;

AGED; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DORSOLATERAL PREFRONTAL CORTEX; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SCHIZOPHRENIA; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; GRAY MATTER; METABOLISM; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT;

AGED; ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; FEMALE; GRAY MATTER; HALOPERIDOL; HUMANS; MALE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PREFRONTAL CORTEX; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 84955214042     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.06.002     Document Type: Article

References (49)

1. Banerjee, A., Wang, H.Y., Borgmann-Winter, K.E., MacDonald, M.L., Kaprielian, H., Stucky, A., Kvasic, J., Egbujo, C., Ray, R., Talbot, K., Hemby, S.E., Siegel, S.J., Arnold, S.E., Sleiman, P., Chang, X., Hakonarson, H., Gur, R.E., Hahn, C.G., 2014. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia. Mol. Psychiatry (in press).
2. Bauer, D.E., Haroutunian, V., McCullumsmith, R.E., Meador-Woodruff, J.H., 2009. Expression of four housekeeping proteins in elderly patients with schizophrenia. J. Neural Transm. 116 (4), 487-491.
3. Bauer, D., Haroutunian, V., Meador-Woodruff, J.H., McCullumsmith, R.E., 2010. Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia. Schizophr. Res. 117 (1), 92-98.
4. Colley, K.J., 1997. Golgi localization of glycosyltransferases: more questions than answers. Glycobiology 7 (1), 1-13.
5. de Bartolomeis, A., Latte, G., Tomasetti, C., Iasevoli, F., 2014. Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevence to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Mol. Neurobiol. 49, 484-511.
6. Dennis, J.W., Lau, K.S., Demetriou, M., Nabi, I.R., 2009. Adaptive regulation at the cell surface by N-glycosylation. Traffic 10 (11), 1569-1578.
7. Deo, A., Cahill, M., Li, S., Goldszer, I., Henteleff, R., Vanleeuwen, J., Rafalovich, I., Gao, R., Stachowski, E., Sampson, A., Lewis, D., Penzes, P., Sweet, R., 2012. Increased expression of Kalirin-9 in the auditory cortex of schizophrenia subjects: its role in dendritic pathology. Neurobiol. Dis. 45 (2), 796-803.
8. Drummond, J.B., Tucholski, J., Haroutunian, V., Meador-Woodruff, J.H., 2013. Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia. Schizophr. Res. 147 (1), 32-38.
9. Eletr, Z.M., Wilkinson, K.D., 2014. Regulation of proteolysis by deubiquitinating enzymes. Biochim. Biophys. Acta 1843 (1).
10. Goldstein, I.J., 2002. Lectin structure-activity: the story is never over. J. Agric. Food Chem. 50, 6583-6585.
11. Gu, W., Fukuda, T., Isaji, T., Hang, Q., Lee, H., Sakai, S., Morise, J., Mitoma, J., Higashi, H., Taniguchi, N., Yawo, H., Oka, S., Gu, J., 2015. Loss of a1, 6-fucosyltransferase decreased hippocampal long-term potentiation: implications for core fucosylation in the regulation of AMPA receptor heteromerization and cellular signaling. J. Biol. Chem. (in press).
12. Hammond, J.C., McCullumsmith, R.E., Funk, A.J., Haroutunian, V., Meador-Woodruff, J.H., 2010. Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia. Neuropsychopharmacology 35 (10), 2110-2119.
13. Harte, M.K., Bachus, S.B., Reynolds, G.P., 2005. Increased N-acetylaspartate in rat striatum following long-termadministration of haloperidol. Schizophr. Res. 75 (2-3), 303-308.
14. Helenius, A., Aebi, M., 2004. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73, 1019-1049.
15. Ishida, H., Togayachi, A., Sakai, T., Iwai, T., Hiruma, T., Sato, T., Okubo, R., Inaba, N., Kudo, T., Gotoh, M., Shoda, J., Tanaka, N., Narimatsu, H., 2004. A novel ß1, 3-Nacetylglucosaminyltransferase (ß3Gn-T8), which synthesizes poly-Nacetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett. 579 (2005), 71-78.
16. Kashihara, K., Sato, M., Fujiwara, Y., Harada, T., Ogawa, T., Otsuki, S., 1986. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain. Biol. Psychiatry 21 (7), 650-656.
17. Khoury, G.A., Baliban, R.C., Floudas, C.A., 2011. Proteome-wide post-translational modification statistics: frequency analysis and curation of the Swiss-Prot database. Sci. Rep. 1 (90).
18. Kittler, J.T., McAinsh, K., Moss, S.J., 2002. Mechanisms of GABAA receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission. Mol. Neurobiol. 26 (2-3), 251-268.
19. Kristiansen, L.V., Patel, S.A., Haroutunian, V., Meador-Woodruff, J.H., 2010. Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia. Synapse 64 (7), 495-502.
20. Lau, K.S., Dennis, J.W., 2008. N-glycans in cancer progression. Glycobiology 18 (10), 750-760.
21. Lipska, B.K., Mitkus, S.N., Mathew, S.V., Fatula, R., Hyde, T.M., Weinberger, D.R., Kleinman, J.E., 2006. Functional genomics in postmortem human brain: abnormalities in a DISC1 molecular pathway in schizophrenia. Dialogues Clin. Neurosci. 8, 353-357.
22. MacDonald, A.W., Schultz, S.C., 2009. What we know: findings that every theory of schizophrenia should explain. Schizophr. Bull. 35 (3), 493-508.
23. Maguire, T.M., Thakore, J., Dinan, T.G., Hopwood, S., Breen, K.C., 1997. Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function. Biol. Psychiatry 41 (11), 1131-1136.
24. McCaffrey, G., Jamieson, J.C., 1993. Evidence for the role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6sialtransferase from rat and mouse liver in whole-cell systems. Comp. Biochem. Physiol. 104, 91-94.
25. Moremen, K.W., Tiemeyer, M., Nairn, A.V., 2012. Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13 (7), 448-462.
26. Mueller, T.M., Haroutunian, V., Meador-Woodruff, J.H., 2014. N-Glycosylation of GABAA receptor subunits is altered in schizophrenia. Neuropsychopharmacology 39 (3), 528-537.
27. Mueller, T.M., Remedies, C.E., Haroutunian, V., Meador-Woodruff, J.H., 2015. Abnormal subcellular localization of GABAA receptor subunits in schizophrenia brain. Transl. Psychiatry (in press).
28. Narayan, S., Head, S.R., Gilmartin, T.J., Dean, B., Thomas, E.A., 2009. Evidence for disruption of sphingolipid metabolism in schizophrenia. J. Neurosci. Res. 87 (1), 278-288.
29. Ohtsubo, K., Marth, J.D., 2006. Glycosylation in cellular mechanisms of health and disease. Cell 126 (5), 855-867.
30. Parodi, A.J., 2000. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem. J. 348 (1), 1-13.
31. Partridge, E.A., Le Roy, C., Di Guglielmo, G.M., Pawling, J., Cheung, P., Granocsky, M., Nabi, I.R., Wrana, J.L., Dennis, J.W., 2004. Regulation of cytokine receptors by golgi N-glycan processing and endocytosis. Science 306, 120-124.
32. Pinner, A.L., Haroutunian, V., Meador-Woodruff, J.H., 2014. Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia. Schizophr. Res. 154 (1-3), 36-41.
33. Powchik, P., Davidson, M., Haroutunian, V., Gabriel, S.M., Purohit, D.P., Perl, D.P., Harvey, P.D., Davis, K.L., 1998. Postmortem studies in schizophrenia. Schizophr. Bull. 24 (3), 325-341.
34. Purohit, D.P., Perl, D.P., Haroutunian, V., Powchik, P., Davidson, M., Davis, K.L., 1998. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry 55 (3), 205-211.
35. Rini, J., Esko, J., A. V., 2009. Glycosyltransferases and Glycan-processing Enzymes. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
36. Rubio, M.D., Wood, K., Haroutunian, V., Meador-Woodruff, J.H., 2013. Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia. Neuropsychopharmacology 38 (10), 1910-1920.
37. Schachter, H., 1986. Biosynthetic controls that determine the branching andmicroheterogeneity of protein-bound oligosaccharides. Biochem. Cell Biol. 64, 163-181.
38. Schachter, H., 2000. The joys of HexNAc. The synthesis and function of N-and O-glycan branches. Glycoconj. J. 17, 465-483.
39. Shan, D., Mount, D., Moore, S., Haroutunian, V., Meador-Woodruff, J.H., McCullumsmith, R.E., 2014. Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia. Schizophr. Res. 154 (1-3), 1-13.
40. Sola, R.J., Griebenow, K., 2009. Effects of glycosylation on the stability of protein pharmaceuticals. J. Pharm. Sci. 98 (4), 1223-1245.
41. Stan, A.D., Ghose, S., Gao, X.-M., Roberts, R.C., Lewis-Amezcua, K., Hatanpaa, K.J., Tamminga, C.A., 2006. Human postmortem tissue: what quality markers matter? Brain Res. 1123 (1), 1-11.
42. Stanta, J.L., Saldova, R., Struwe, W.B., Byrne, J.C., Leweke, F.M., Rothermund, M., Rahmoune, H., Levin, Y., Guest, P.C., Bahn, S., Rudd, P.M., 2010. Identification of Nglycosylation changes in the CSF and serum in patients with schizophrenia. J. Proteome Res. 9 (9), 4476-4489.
43. Talbot, K., Louneva, N., Cohen, J.W., Kazi, H., Blake, D.J., Arnold, S.E., 2011. Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specificmanner indicating their subsynaptic location. PLoS 6 (3), e16886.
44. Tang, J., Liao, Y., Zhou, B., Tan, C., Liu, W., Wang, D., Liu, T., Hao, W., Tan, L., Chen, X., 2012. Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study. PLoS 7 (7), e40247.
45. Thompson, P.M., Sower, A.C., Perrone-Bizzozero, N.I., 1998. Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol. Psychiatry 34 (4), 239-243.
46. Tucholski, J., Simmons, M.S., Pinner, A.L., Haroutunian, V., McCullumsmith, R.E., Meador-Woodruff, J.H., 2013a. Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia. Schizophr. Res. 146 (1-3), 177-183.
47. Tucholski, J., Simmons, M.S., Pinner, A.L., McMillan, L.D., Haroutunian, V., Meador-Woodruff, J.H., 2013b. N-linked glycosylation of cortical N-methyl-D-aspartate and kainate receptor subunits in schizophrenia. Neuroreport 24 (12), 688-691.
48. Tucholski, J., Pinner, A.L., Simmons, M.S., Meador-Woodruff, J.H., 2014. Evolutionarily conserved pattern of AMPA receptor subunit glycosylation in mammalian frontal cortex. PLoS 9 (4), e94255.
49. Wagner, S.A., Beli, P., Weinert, B.T., Nielsen, M.L., Cox, J., Mann, M., Choudhary, C., 2011. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 10 (10) (M111.013284).